Table 1.
Point prevalence malaria infection at study visits
| Study visit | No infection % (n) |
Submicroscopic infection % (n) |
Microscopic infection % (n) |
|---|---|---|---|
| Enrolment (n = 2190) | |||
| P. falciparuma | 90.2 (1976) | 5.1 (111) | 4.7 (103) |
| P. vivax mono-infection | 97.2 (2129) | 2.2 (48) | 0.6 (13) |
| Second study visit (n = 1015) | |||
| P. falciparum | 98.5 (1000) | 0.7 (7) | 0.8 (8) |
| Third study visit (n = 859) | |||
| P. falciparum | 97.8 (841) | 1.1 (9) | 1.1 (9) |
| Delivery—peripheral blood (n = 1936) | |||
| P. falciparum | 96.5 (1869) | 1.5 (29) | 2.0 (38) |
| P. vivax mono-infection | 98.3 (1904) | 1.6 (30) | 0.1 (2) |
| Delivery—placental blood (n = 1300) | |||
| P. falciparumb | 96.6 (1256) | 1.1 (14) | 2.3 (30) |
| P. vivax mono-infection | 99.5 (1293) | 0.5 (7) | 0.0 (0) |
a P. falciparum mono-infection or mixed infection with P. vivax (n = 12)
b P. falciparum mono-infection or mixed infection with P. vivax (n = 1)